Articles That Should Change NICU Care in 2023

---

ONLINECMECNENEO Grand Rounds

Instructions

Monday, June 12, 2023, 8:00 AM - Thursday, June 11, 2026, 11:59 PM, Online


AMA PRA Category 1 Credits™ (1.25 hours), ANCC Nursing Contact Hour(s) (1.25 hours), Non-Physician (Attendance) (1.25 hours)

This activity will provide information and analysis on recently published studies in the areas of steroid treatment, early amino acid use, and neonatal opioid withdrawal.

1. Discuss the associations between maternal antenatal corticosteroid treatment and rates of psychological developmental and neurosensory disorders in children.
2. Describe the association of corticosteroid therapy for bronchopulmonary dysplasia in extremely preterm infants and risk of death or disability.
3. Discuss NICE recommendations for genetic testing to prevent deafness from antibiotics in newborn babies.
4. Discuss the impact of the use of early amino acids for extremely preterm infants on neurodisability at 2 years.
5. Describe the results of a recent clinical trial comparing eat, sleep, console approach, or usual care for neonatal opioid withdrawal.
6. Define maternal opioid use disorder and the risk of post-neonatal infant mortality.

1. Discuss the associations between maternal antenatal corticosteroid treatment and rates of psychological developmental and neurosensory disorders in children.
2. Describe the association of corticosteroid therapy for bronchopulmonary dysplasia in extremely preterm infants and risk of death or disability.
3. Discuss NICE recommendations for genetic testing to prevent deafness from antibiotics in newborn babies.
4. Discuss the impact of the use of early amino acids for extremely preterm infants on neurodisability at 2 years.
5. Describe the results of a recent clinical trial comparing eat, sleep, console approach, or usual care for neonatal opioid withdrawal.
6. Define maternal opioid use disorder and the risk of post-neonatal infant mortality.

The Pediatrix Center for Research, Education, Quality and Safety is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Pediatrix Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

---

The Pediatrix Center for Research, Education, Quality and Safety is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The Pediatrix Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 1.25 nursing contact hour(s). Participants should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

The Pediatrix Center for Research, Education, Quality and Safety adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies during the past 24 months prior to their involvement with the CE activity. All relevant financial relationships have been mitigated prior to the commencement of the activity.

There is no commercial support for this educational activity.